Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PublicSquare Says FY24 Revenue, Profitability, And Cash Position Outlook Remain Unchanged

Author: Benzinga Newsdesk | May 15, 2024 06:39am
Year-End 2024 Exit Run-Rate Revenue of approximately $47 million to $53 million
  • EveryLife is expected to reach and maintain cash flow positivity during 2024
  • Credova is expected to remain cash flow positive in 2024
  • PublicSquare intends to prioritize the development and growth of PSQPayments

 

  • Expect to exit 2024 with approximately $8.0 million to $10.0 million of cash on the balance sheet

Posted In: PSQH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)
CORE Finalist